Chromatin profiling identifies chondrocyte-specific Sox9 enhancers important for skeletal development
JCI Insight · 10.06.2024 · 9 (11)
DOI: 10.1172/jci.insight.175486 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, online erschienen am 10.06.2024. Verfasst von Sachi Ichiyama-Kobayashi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Biochemistry. Hauptthemen laut MEDLINE: SOX9 Transcription Factor, Chondrocytes, Campomelic Dysplasia, Chondrogenesis. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Mochida Memorial Foundation for Medical and Pharmaceutical Research.
Abstract (Originalsprache)
The transcription factor SRY-related HMG box 9 (Sox9) is essential for chondrogenesis. Mutations in and around SOX9 cause campomelic dysplasia (CD) characterized by skeletal malformations. Although the function of Sox9 in this context is well studied, the mechanisms that regulate Sox9 expression in chondrocytes remain to be elucidated. Here, we have used genome-wide profiling to identify 2 Sox9 enhancers located in a proximal breakpoint cluster responsible for CD. Enhancer activity of E308 (located 308 kb 5′ upstream) and E160 (located 160 kb 5′ upstream) correlated with Sox9 expression levels, and both enhancers showed a synergistic effect in vitro. While single deletions in mice had no apparent effect, simultaneous deletion of both E308 and E160 caused a dwarf phenotype, concomitant with a reduction of Sox9 expression in chondrocytes. Moreover, bone morphogenetic protein 2–dependent chondrocyte differentiation of limb bud mesenchymal cells was severely attenuated in E308/E160 deletion mice. Finally, we found that an open chromatin region upstream of the Sox9 gene was reorganized in the E308/E160 deletion mice to partially compensate for the loss of E308 and E160. In conclusion, our findings reveal a mechanism of Sox9 gene regulation in chondrocytes that might aid in our understanding of the pathophysiology of skeletal disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Cellular Biochemistry.
- Department of Oral and Maxillofacial Oncology and Surgery, and.
- Genome Editing Research and Development Unit, Osaka University Graduate School of Dentistry, Suita, Osaka, Japan.
- Department of Cell Biology, Cancer Institute, Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan.
Förderung
- Japan Society for the Promotion of Science
- Mochida Memorial Foundation for Medical and Pharmaceutical Research
Zitieren
APA
Ichiyama-Kobayashi, S., Hata, K., Wakamori, K., Takahata, Y., Murakami, T., Yamanaka, H., Takano, H., Yao, R., Uzawa, N., & Nishimura, R. (2024). Chromatin profiling identifies chondrocyte-specific Sox9 enhancers important for skeletal development. JCI Insight, 9(11). https://doi.org/10.1172/jci.insight.175486
Vancouver
Ichiyama-Kobayashi S, Hata K, Wakamori K, Takahata Y, Murakami T, Yamanaka H, et al. Chromatin profiling identifies chondrocyte-specific Sox9 enhancers important for skeletal development. JCI Insight. 2024;9(11). doi:10.1172/jci.insight.175486
BibTeX
@article{IchiyamaKobayashi2024,
author = {Ichiyama-Kobayashi, Sachi and Hata, Kenji and Wakamori, Kanta and Takahata, Yoshifumi and Murakami, Tomohiko and Yamanaka, Hitomi and Takano, Hiroshi and Yao, Ryoji and Uzawa, Narikazu and Nishimura, Riko},
title = {Chromatin profiling identifies chondrocyte-specific Sox9 enhancers important for skeletal development},
journal = {JCI Insight},
year = {2024},
volume = {9},
number = {11},
doi = {10.1172/jci.insight.175486}
}
EUVIMED